Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Evdokia Anagnostou, Mount Sinai School of Medicine
ClinicalTrials.gov Identifier:
NCT00263796
First received: December 7, 2005
Last updated: April 28, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)